Bob Hopkins
Stock Analyst at B of A Securities
(1.00)
# 3,640
Out of 4,854 analysts
55
Total ratings
56.1%
Success rate
-21.97%
Average return
Main Sectors:
Stocks Rated by Bob Hopkins
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INSP Inspire Medical Systems | Upgrades: Buy | $220 → $255 | $136.02 | +87.47% | 5 | Nov 20, 2024 | |
| BSX Boston Scientific | Maintains: Buy | $90 → $100 | $102.09 | -2.05% | 5 | Oct 22, 2024 | |
| SGHT Sight Sciences | Downgrades: Underperform | $10 → $4.5 | $4.21 | +6.89% | 4 | Sep 13, 2023 | |
| PRCT PROCEPT BioRobotics | Initiates: Buy | $48 | $62.91 | -23.70% | 1 | Oct 11, 2021 | |
| ABT Abbott Laboratories | Maintains: Buy | $133 | $133.58 | -0.43% | 2 | Aug 31, 2021 | |
| LUNG Pulmonx | Upgrades: Buy | $72 | $3.16 | +2,178.48% | 2 | Mar 10, 2021 | |
| ISRG Intuitive Surgical | Downgrades: Neutral | $242 → $253 | $557.08 | -54.53% | 7 | Sep 8, 2020 | |
| PEN Penumbra | Downgrades: Neutral | n/a | $258.90 | - | 2 | Sep 8, 2020 | |
| TNDM Tandem Diabetes Care | Maintains: Neutral | $85 → $95 | $20.78 | +357.17% | 5 | May 22, 2020 | |
| JNJ Johnson & Johnson | Upgrades: Buy | n/a | $155.03 | - | 2 | Apr 22, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $37 → $30 | $95.33 | -68.53% | 2 | Oct 31, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $98 → $105 | $87.44 | +20.08% | 7 | Aug 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $73 → $83 | $30.26 | +174.29% | 6 | May 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $260 | $173.45 | +49.90% | 4 | Jan 19, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $59.92 | - | 1 | Nov 10, 2017 |
Inspire Medical Systems
Nov 20, 2024
Upgrades: Buy
Price Target: $220 → $255
Current: $136.02
Upside: +87.47%
Boston Scientific
Oct 22, 2024
Maintains: Buy
Price Target: $90 → $100
Current: $102.09
Upside: -2.05%
Sight Sciences
Sep 13, 2023
Downgrades: Underperform
Price Target: $10 → $4.5
Current: $4.21
Upside: +6.89%
PROCEPT BioRobotics
Oct 11, 2021
Initiates: Buy
Price Target: $48
Current: $62.91
Upside: -23.70%
Abbott Laboratories
Aug 31, 2021
Maintains: Buy
Price Target: $133
Current: $133.58
Upside: -0.43%
Pulmonx
Mar 10, 2021
Upgrades: Buy
Price Target: $72
Current: $3.16
Upside: +2,178.48%
Intuitive Surgical
Sep 8, 2020
Downgrades: Neutral
Price Target: $242 → $253
Current: $557.08
Upside: -54.53%
Penumbra
Sep 8, 2020
Downgrades: Neutral
Price Target: n/a
Current: $258.90
Upside: -
Tandem Diabetes Care
May 22, 2020
Maintains: Neutral
Price Target: $85 → $95
Current: $20.78
Upside: +357.17%
Johnson & Johnson
Apr 22, 2020
Upgrades: Buy
Price Target: n/a
Current: $155.03
Upside: -
Oct 31, 2019
Maintains: Underperform
Price Target: $37 → $30
Current: $95.33
Upside: -68.53%
Aug 22, 2018
Maintains: Buy
Price Target: $98 → $105
Current: $87.44
Upside: +20.08%
May 22, 2018
Maintains: Buy
Price Target: $73 → $83
Current: $30.26
Upside: +174.29%
Jan 19, 2018
Reinstates: Buy
Price Target: $260
Current: $173.45
Upside: +49.90%
Nov 10, 2017
Upgrades: Neutral
Price Target: n/a
Current: $59.92
Upside: -